Browsing Tag
China
666 posts
Xi warns Trump on Taiwan as US and China push trade deals in Beijing
Trump and Xi are chasing trade stability. Taiwan remains the fault line that could still pull United States China ties into crisis.
May 15, 2026
Iran ceasefire on life support as Trump rejects Tehran proposal sent through Pakistan
Iran wants sanctions relief and Hormuz leverage. Trump wants nuclear concessions. The ceasefire is now the conflict’s weakest link.
May 12, 2026
Tata Steel (NSE: TATASTEEL) heads into Q4 results near its 52-week high
TATASTEEL is near its high before Q4 results. India growth supports the bull case, but Europe and steel prices may decide FY27.
May 10, 2026
DOJ seeks to revoke citizenship of 12 foreign born Americans over alleged fraud and crimes
Citizenship is secure until fraud enters the file. DOJ’s 12 denaturalization cases test how far Trump’s immigration crackdown can go.
May 10, 2026
BioQ’s in-cosmetics Global debut signals China’s deeper push into beauty ingredient innovation
China’s skincare race is moving upstream. BioQ’s Paris debut shows why ingredient control may become GUYU’s bigger global advantage.
May 8, 2026
Oil markets face fresh volatility as US and Iran fighting threatens supply confidence
Brent crude is back above $100. United States and Iran tensions have turned Strait of Hormuz risk into the market’s key inflation threat.
May 8, 2026
BHP Group (ASX: BHP) leads ASX 200 miners higher as copper thesis reignites supercycle trade
Base metals are flat. Iron ore hasn't moved. So why is BHP Group ripping the ASX 200 to a two-week high? The copper thesis is back in play.
May 7, 2026
U.S.-Iran talks gain momentum, but the nuclear question still blocks a final deal
A Gulf war deal may be near, but Iran’s nuclear program and Hormuz access remain unresolved. The next 30 days could define the settlement.
May 7, 2026
Why Cochlear (ASX: COH) is bouncing despite a 40.5% drop since the April FY26 downgrade
Cochlear bounced 2.31% today, but the stock sits 40% below pre-downgrade levels. The August FY26 result is where management's recovery thesis either holds or breaks.
May 4, 2026
The a2 Milk Company recalls U.S. infant formula batches as cereulide detection sparks market sell-off
The a2 Milk Company faces investor scrutiny after a U.S. infant formula recall. Read how the risk could affect brand trust and strategy.
May 4, 2026